Odiparcil (Standard)
Odiparcil (Standard) is the analytical standard of Odiparcil (HY-10277). This product is intended for research and analytical applications. Odiparcil (SB-424323) is an orally active β-D-xyloside derivative. Odiparcil can effectively divert the synthesis of cellular glycosaminoglycans (GAG) into secreted soluble species and reduce GAG accumulation. Odiparcil shows antithrombin and antiplatelet activity. Odiparcil can be used for the researches of metabolic and cardiovascular disease, such as mucopolysaccharidoses (MPS) and thrombosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 137215-12-4
- Formule: C15H16O6S
- Masse moléculaire:324.35
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-10277
Odiparcilβ-D-xyloside Derivative -
HY-10787
XimelagatranThrombin Inhibitor -
HY-B0375
ArgatrobanThrombin Inhibitor -
HY-10163
DabigatranThrombin Inhibitor -
HY-10274A
Dabigatran etexilate mesylateAntithrombotic Agent -
HY-B0375A
Argatroban monohydrateThrombin Inhibitor -
HY-10163R
Dabigatran (Standard)Thrombin Inhibitor -
HY-129056
MelagatranThrombin Inhibitor -
HY-10274
Dabigatran etexilateAntithrombotic Agent -
HY-B0375R
Argatroban (Standard)Thrombin Inhibitor -
HY-B0209
MetolazoneDiuretics -
HY-P1000
TRAP-14Thrombin Receptor Agonist
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 137215-12-4
-
Masse moléculaire 324.35
-
Formule C15H16O6S
-
SMILES
CC(C1=CC=C(O[C@H]2[C@@H]([C@H]([C@@H](CS2)O)O)O)C=C1O3)=CC3=O
-
Synonyms
SB-424323 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Entchev E, et al. Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models. PLoS One. 2020 May 15;15(5):e0233032. [Content Brief]
[2]. Toomey JR, et al. A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis. J Thromb Haemost. 2006 Sep;4(9):1989-96. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Odiparcil (Standard) Related Classifications
HY-10277R Related Classifications
Powered by Bioz